- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
Snapshot for Merck & Co Inc (MRK)
| Open: | 47.7100 | Day's Range: | 47.4500 - 48.1700 | Volume: | 18,000,478 |
|---|---|---|---|---|---|
| Previous Close: | 47.7500 | 52wk Range: | 38.8600 - 50.1600 | 1-Yr Rtn: | +26.00% |
Key Statistics for MRK
| Current P/E Ratio (ttm) | 12.9293 |
|---|---|
| Estimated P/E(12/2013) | 13.5209 |
| Relative P/E vs. SPX | 0.8103 |
| Earnings Per Share (USD) (ttm) | 3.6800 |
| Est. EPS (USD) (12/2013) | 3.5190 |
| Est. PEG Ratio | 3.2874 |
| Market Cap (M USD) | 143,673.14 |
| Shares Outstanding (M) | 3,019.61 |
| 30 Day Average Volume | 23,098,340 |
| Price/Book (mrq) | 2.7073 |
| Price/Sale (ttm) | 3.1363 |
| Dividend Indicated Gross Yield | 3.62% |
| Cash Dividend (USD) | 0.4300 |
| Last Dividend | 06/13/2013 |
| 5 Year Dividend Growth | 2.38% |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for MRK
Company Profile & Key Executives for MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care.
| Kenneth C Frazier "Ken"Chairman/President/CEO | Peter N KelloggExec VP/CFO |
| Clark GolestaniExec VP/Chief Information Ofcr | Michael J HolstonExec VP/Chief Ethics Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
MRK News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page